1. Chung YG, Won YS, Kwon YJ, Shin HC, Choi CS, Yeom JS. Comparison of serum CRP and procalcitonin in patients after spine surgery. J Korean Neurosurg Soc. 2011; 49:43–48. PMID:
21494362.
Article
2. Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med. 1999; 17:1019–1025. PMID:
10595891.
Article
3. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol. 2010; 48:2325–2329. PMID:
20421436.
Article
4. Hadjipavlou AG, Mader JT, Necessary JT, Muffoletto AJ. Hematogenous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976). 2000; 25:1668–1679. PMID:
10870142.
Article
5. Jeong SJ, Choi SW, Youm JY, Kim HW, Ha HG, Yi JS. Microbiology and epidemiology of infectious spinal disease. J Korean Neurosurg Soc. 2014; 56:21–27. PMID:
25289121.
Article
6. Jung SW, Park KH, Kim TW, Kim JO, Kim JC. A clinical analysis of postoperative lumbar spondylodiscitis. Korean J Spine. 2005; 2:38–45.
7. Kaya S, Ercan S, Kaya S, Aktas U, Kamasak K, Ozalp H, et al. Spondylodiscitis : evaluation of patients in a tertiary hospital. J Infect Dev Ctries. 2014; 8:1272–1276. PMID:
25313603.
Article
8. Kim CJ, Song KH, Jeon JH, Park WB, Park SW, Kim HB, et al. A comparative study of pyogenic and tuberculous spondylodiscitis. Spine (Phila Pa 1976). 2010; 35:E1096–E1100. PMID:
20838270.
Article
9. Kim KE, Han JY. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection. Korean J Lab Med. 2010; 30:153–159. PMID:
20445333.
Article
10. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013; 28:285–291. PMID:
23682219.
Article
11. Lee KS, Doh JW, Bae HG, Yun IG. Primary infections disorders of the spine : report of 40 cases. J Korean Neurosurg Soc. 1996; 25:1655–1660.
12. Lee KY, Sohn SK, Hwang KS. Comparison of pyogenic and tuberculous spondylitis. J Korean Soc Spine Surg. 1999; 6:443–450.
13. Luzzati R, Giacomazzi D, Danzi MC, Tacconi L, Concia E, Vento S. Diagnosis, management and outcome of clinically- suspected spinal infection. J Infect. 2009; 58:259–265. PMID:
19268368.
Article
14. Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000; 28:977–983. PMID:
10809269.
Article
15. Nie H, Jiang D, Ou Y, Quan Z, Hao J, Bai C, et al. Procalcitonin as an early predictor of postoperative infectious complications in patients with acute traumatic spinal cord injury. Spinal Cord. 2011; 49:715–720. PMID:
21243003.
Article
16. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000; 28:458–461. PMID:
10708183.
Article
17. Olshaker JS, Jerrard DA. The erythrocyte sedimentation rate. J Emerg Med. 1997; 15:869–874. PMID:
9404806.
Article
18. Pintado-García V. [Infectious spondylitis]. Enferm Infecc Microbiol Clin. 2008; 26:510–517. PMID:
19094866.
19. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther. 2010; 8:575–587. PMID:
20455686.
Article
20. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions : past, present and future. BMC Med. 2011; 9:107. PMID:
21936959.
21. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection : a systematic review and meta-analysis. Clin Infect Dis. 2004; 39:206–217. PMID:
15307030.
Article